** Shares of Sigma Healthcare SIG.AX fall as much as 7% to A$2.930, their lowest levels since April 9

** Stock logs its biggest intraday pct gain since mid-December 2024

** SIG among top worst performers in the benchmark index

** UBS retains "neutral" rating, needs more conviction in the retail pharmacy franchiser's international growth outlook

** Co says 9-month normalised EBIT (unaudited) growth for combined group, compared with pcp for Chemist Warehouse Group (CWG) broadly consistent with the 36% growth achieved by CWG for 1H FY25

** Sigma Healthcare completed merger with CWG on February 12

** Average rating of eight analysts is "hold", their median PT is A$2.80 – according to data compiled by LSEG

(Reporting by Sneha Kumar in Bengaluru)

((Sneha.kumar@thomsonreuters.com;))